EMMBF - Emblem Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.903
-0.082 (-8.32%)
At close: 3:57PM EST
Stock chart is not supported by your current browser
Previous Close0.985
Open0.000
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.000 - 0.000
52 Week Range
Volume0
Avg. Volume399,909
Market Cap109.964M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.109
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswireyesterday

    Canntab Corporate Update

    Canntab Therapeutics Limited (CSE: PILL, FSE: TBF1) (“Canntab” or the “Company”) is a company with a clear vision of becoming the leader in solid oral dosage formulation of cannabis.  Their unique products offer advantages to the medical community, patients, adult use consumers and governments.  Canntab is pleased to provide this corporate update to its shareholders. A strong intellectual property portfolio with 13 patents pending in the United States and Canada pertaining to the formulation of tablets including instant release, extended release, flash melt and bi-layered. An application to become a Licensed Producer (Non Grower) under the Access to Cannabis for Medical Purposes Regulations and has confirmation from Health Canada that its application had been received.

  • GlobeNewswire8 days ago

    Emblem Corp. announces new board appointments

    Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) today announced the appointment of Connie A. Stefankiewicz and Loreto Grimaldi to its Board of Directors (the “Board”) following Emblem’s annual and special shareholders’ meeting. Harvey Shapiro, current chair, and Maxim Zavet have stepped down from the Board, and the Board would like to thank them for their immense contributions since Emblem’s inception. Ms. Stefankiewicz and Mr. Grimaldi will join current Board members Daniel Milliard, Jeffrey Fineberg, John H. Stewart, Terry Johnson and Nick Dean.

  • GlobeNewswire22 days ago

    Emblem finalizes agreement to launch Emblem Germany in joint venture with Acnos Pharma

    TORONTO, Oct. 24, 2018 (GLOBE NEWSWIRE) --  Emblem Corp.  (TSXV: EMC, OTCQX:EMMBF) ("Emblem" or the "Company"), today announced that, through its wholly-owned subsidiary Emblem Cannabis Corporation (“ECC”), it has signed a definitive agreement with German pharmaceutical wholesaler Acnos Pharma GmbH (“Acnos”) in respect to launching a joint venture under the name “Emblem Germany” (the “JV”) for the purpose of exporting Emblem-branded cannabis products from Canada into Germany. The JV – owned 60% by ECC and 40% owned by Acnos – will allow Emblem to commence exporting its products to Germany, with first deliveries expected to be made in mid-2019.

  • VIDEO + B-ROLL: Emblem Corp. CEO Nick Dean welcomes Canada-wide adult-use cannabis legalization
    CNW Group29 days ago

    VIDEO + B-ROLL: Emblem Corp. CEO Nick Dean welcomes Canada-wide adult-use cannabis legalization

    VIDEO + B-ROLL: Emblem Corp. CEO Nick Dean welcomes Canada-wide adult-use cannabis legalization

  • Emblem Establishes Temporary "Patient Access Investment Fund" to Partially Cover Medical Cannabis Excise Tax
    CNW Grouplast month

    Emblem Establishes Temporary "Patient Access Investment Fund" to Partially Cover Medical Cannabis Excise Tax

    TORONTO , Oct. 15, 2018 /CNW/ - Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) ("Emblem" or the "Company") today announced that it will segregate CDN $5 million of its current cash holdings to establish what it is calling the Patient Access Investment Fund (the "Fund"), the interest from which will be used to help offset some of the cost of the excise tax that will be applied to medical cannabis products, effective October 17, 2018 . On October 17 , the Access to Cannabis for Medical Purposes Regulations ("ACMPR") will be replaced by the Cannabis Act, and all Licensed Producers will be required to collect and submit a federal cannabis excise tax to the government. The standard rate tax is the greater of $1.00 /gram equivalent or 10% of the purchase price, with some provinces requiring an additional excise duty adjustment on top, which can range as high as 19.3% (the "New Excise Tax").

  • GlobeNewswirelast month

    Emblem Establishes Temporary “Patient Access Investment Fund” to Partially Cover Medical Cannabis Excise Tax

    Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) ("Emblem" or the "Company") today announced that it will segregate CDN $5 million of its current cash holdings to establish what it is calling the Patient Access Investment Fund (the “Fund”), the interest from which will be used to help offset some of the cost of the excise tax that will be applied to medical cannabis products, effective October 17, 2018. On October 17, the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) will be replaced by the Cannabis Act, and all Licensed Producers will be required to collect and submit a federal cannabis excise tax to the government. The standard rate tax is the greater of $1.00/gram equivalent or 10% of the purchase price, with some provinces requiring an additional excise duty adjustment on top, which can range as high as 19.3% (the “New Excise Tax”).

  • GlobeNewswirelast month

    A Letter from Emblem’s President & CEO

    Emblem continues to bring innovative products to market, most recently with the launch of Atmosphere oral sprays, and we’re firmly executing on our three-year strategy. Most notably, in the third quarter we executed a strategic pivot in our approach to cannabis production, cancelling our capital-intensive production plans, and instead electing to take advantage of the significant wholesale supply capacity coming online industry-wide. In practical terms this gives Emblem access to ample capacity, while freeing up our capital resources to focus on our passion for innovative value-added products where we already realize higher margin profiles.

  • GlobeNewswirelast month

    Emblem to supply British Columbia and Saskatchewan markets with high quality cannabis

    Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) (“Emblem” or the "Company") today announced that its wholly-owned subsidiary, Emblem Cannabis Corporation, one of Canada’s leading licensed producers of medical cannabis, has received approval to supply British Columbia and Saskatchewan with premium cannabis products under Emblem’s adult-use brand, Symbl. In B.C., Emblem has been approved to supply cannabis to the BC Liquor Distribution Branch (“BCLDB”) – the sole, wholesale distributor of non-medical cannabis for the province that will operate standalone, public retail stores and provide online sales. In Saskatchewan, Emblem has been approved by the Saskatchewan Liquor and Gaming Authority (“SLGA”) to supply cannabis to the province’s private retail market.

  • GlobeNewswirelast month

    Emblem Bolsters Medical Division to Support Growth and Product Innovation with Appointment of Wayne Kreppner as President

    Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) ("Emblem" or the "Company") today announced additional leadership and operational resources to support the rapid growth of its medical division and associated new product innovations. Mr. Stewart will oversee the Division in an advisory capacity and will remain a member of Emblem’s Board of Directors.

  • GlobeNewswire2 months ago

    Emblem Corp. Announces Grant of Stock Options

    Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) announced that the board of directors of the Company has approved the granting of 350,000 incentive stock options (the “Options”) to certain officers of the Company.  The Options are exercisable at a price of $1.60 per share for a period of five years and are subject to vesting as to one-third the number of Options granted on each of September 25, 2019, 2020 and 2021. Emblem, through its wholly-owned subsidiary Emblem Cannabis Corporation, is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the Access to Cannabis for Medical Purposes Regulations. Emblem is also the ultimate parent company of GrowWise Health Ltd., one of Canada’s leading medical cannabis education services.

  • GlobeNewswire2 months ago

    Emblem partners with DriveABLE to support research that evaluates impairment risk

    Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) today announced it has completed an equity investment in DriveABLE Assessment Centres Inc. (“DriveABLE”), a global leader in cognitive-based driving evaluations that measure the risk of impairment. Through this investment – to Emblem’s knowledge, the first of its kind in the cannabis space – Emblem will support DriveABLE as it seeks to tackle the issue of impairment on roads and in the workplace with new mobile technology. Using the knowledge gained from almost two decades of evaluating real world impairment risk in partnership with law enforcement agencies, universities and other industries that operate in safety-sensitive environments, DriveABLE is now developing a mobile cognitive evaluation tool that will focus on the risks associated with impairment.

  • ACCESSWIRE2 months ago

    Marijuana Stocks for Investors - September 2018 Cannabis Investor Magazine for Free

    ATLANTA, GA / ACCESSWIRE / September 24, 2018 / CannaInvestor Magazine, the leading industry investment magazine for cannabis investors, analysts, executives, entrepreneurs, and financial media, announced ...

  • ACCESSWIRE2 months ago

    3 Pot Stocks On The Move After Latest Industry News

    CORAL GABLES, FL / ACCESSWIRE / September 18, 2018 / Cannabis and marijuana stocks are striking up conversation in the market. The looming date in mid October has a number of investors speculating on what is to come for the cannabis industry once Canada is legally selling recreational marijuana across the country. Further to this, a larger cannabis company and one that has recently gone public in the US, Tilray (TLRY) will be "breaking down barriers" and importing medical cannabis into the US.A number of marijuana stocks are heading higher this month and include GTEC Holdings (GGTTF) (GTEC), Emblem Corp. (EMMBF) (EMC.V), and Green Thumb Industries (GTBIF)(TSX:GTII).

  • GlobeNewswire2 months ago

    Emblem and Canntab to Commence Clinical Testing of 12-Hour Extended Release Cannabis Tablets

    TORONTO, Sept. 18, 2018-- Emblem Corp., through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations, ...

  • GlobeNewswire2 months ago

    Emblem and Natura Naturals announce termination of letter of intent

    Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), and Natura Naturals Holdings Inc. (“Natura”) announced the termination of their letter of intent as of 5 p.m. EST on September 13, 2018. In addition, as previously announced, Emblem recently provided $2 million of advanced funding to Natura for the expansion of its facility (the “Funding”). The Funding is comprised of a one-year convertible debenture for an aggregate principal amount of up to $2 million, with an interest rate similar to Natura’s other funding obligations and can be pre-paid at any time during the term.

  • Global Cannabis Partnership Welcomes New Members
    CNW Group2 months ago

    Global Cannabis Partnership Welcomes New Members

    SAINT JOHN, NB , Sept. 13, 2018 /CNW/ - Momentum continues to build for the establishment of a Responsible Cannabis Framework as eight more organizations join the Global Cannabis Partnership (GCP), in its newly opened Member category. "We expect membership to expand as more and more stakeholders recognize the necessity of social responsibility policies and programs and want to be at the table to collaborate," says Kim Wilson , Executive Director of the GCP.

  • Global Cannabis Partnership Welcomes New Members
    PR Newswire2 months ago

    Global Cannabis Partnership Welcomes New Members

    SAINT JOHN, NB, Sept. 13, 2018 /PRNewswire/ - Momentum continues to build for the establishment of a Responsible Cannabis Framework as eight more organizations join the Global Cannabis Partnership (GCP), in its newly opened Member category. "We expect membership to expand as more and more stakeholders recognize the necessity of social responsibility policies and programs and want to be at the table to collaborate," says Kim Wilson, Executive Director of the GCP.

  • ACCESSWIRE2 months ago

    3 Marijuana Stocks in the News this Week

    CORAL GABLES, FL / ACCESSWIRE / September 13, 2018 / Marijuana stocks have come a long way especially since 2014 when Colorado first brought the idea of legal recreation cannabis sales to the forefront. Fast-forwarding to today and we are just over a month away from an entire country "flipping the switch" for legal recreational marijuana sales. In fact, data has emerged estimating that the legal cannabis industry will reach $146.4 billion by 2025, according to Grand View Research.

  • GlobeNewswire2 months ago

    Emblem launches Atmosphere, its first oral dose-metered spray

    TORONTO, Sept. 13, 2018-- Emblem Corp., through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations, ...

  • ACCESSWIRE2 months ago

    3 Pot Stocks Investors are Watching on Wednesday

    There a more licensed producers hitting the public markets all hoping to get a piece of the expanding Canadian marijuana industry. Mid October is when the country will go fully legal for recreational cannabis sales and further open the door for international trade. With this in mind, a number of marijuana stocks are heading higher this month and include GTECHoldings (GGTTF) (GTEC), Emblem Corp. (EMMBF) (EMC), and Green Thumb Industries (GTBIF)(GTII).

  • GlobeNewswire2 months ago

    Emblem signs supply agreement with Aphria to purchase up to 175,000 kg equivalents of cannabis products over five years

    Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), today announced that it has entered into a five-year wholesale supply agreement (the “Agreement”) with Aphria Inc. (“Aphria”) (TSX: APH, US OTC: APHQF). The Agreement will see Emblem purchase up to an aggregate of 175,000 kg equivalents of cannabis products from Aphria over a five-year term (the “Initial Term”), with the opportunity for five-year renewals.

  • GlobeNewswire2 months ago

    Emblem announces proposed investment in Compass Cannabis Clinic, owner of Starbuds Canada

    Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), today announced its intention to purchase approximately $1 million of units (“Units”) of 10330698 Canada Ltd. d/b/a Compass Cannabis Clinic (“Compass”) at a price of $0.60 per Unit. Each Unit will consist of one common share in the capital of Compass (each, a “Compass Share”) and one-half of one common share purchase warrant, with each whole warrant entitling the holder purchase one (1) additional Compass Share at a price of $0.75 per share for a period of twenty-four (24) months, subject to adjustments in certain events. Compass and its wholly owned subsidiary adult-use retail entity Starbuds Canada have forty confirmed leases for locations across Canada, a mix of operational clinics that are now open, in development, or in preparation with the intended use of becoming retail cannabis stores upon legalization on October 17, 2018.

  • GlobeNewswire2 months ago

    UPDATE: Emblem signs five-year supply agreement with Compass Cannabis Clinic for Starbuds Canada

    Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), announced today that it has entered into a five-year supply and preferred vendor agreement (the “Agreement”) with 10330698 Canada Ltd. d/b/a Compass Cannabis Clinic (“Compass”) to become a preferred cannabis supplier through its wholly owned subsidiary adult-use retail entity Starbuds Canada (“Starbuds”), effective October 17, 2018. Compass currently has forty confirmed leases for locations across Canada, a mix of operational clinics that are now open, in development, or in preparation with the intended use of becoming retail cannabis stores.

  • GlobeNewswire2 months ago

    Emblem signs five-year supply agreement with Compass Cannabis Clinic for Starbuds Canada

    Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), announced today that it has entered into a five-year supply and preferred vendor agreement (the “Agreement”) with 10330698 Canada Ltd. d/b/a Compass Cannabis Clinic (“Compass”) to become a preferred cannabis supplier through its wholly owned subsidiary adult-use retail entity Starbuds Canada (“Starbuds”), effective October 17, 2018.

  • GlobeNewswire3 months ago

    Emblem Corp. Advances Funding for Natura Naturals Production

    Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) (“Emblem” or the “Company”) has established a working capital advance (the “Advance”) for Natura Naturals Holdings Inc. (“Natura”) to support the completion of phase 1 construction while the two companies complete due diligence and negotiation of a definitive agreement in connection with the previously announced acquisition of Natura by Emblem. Based in Leamington, Ontario, Natura operates a 662,000 sq. ft licensed greenhouse that is currently undergoing a phased conversion and retrofit. After the completion of phase 1 in 2018, Natura expects to achieve an annual run-rate of 15,000 kgs.